Kyntra Bio, Inc. ( KYNB) - Key Metrics
KYNB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | -$0.36 | $2.96 | -$0.99 | -$0.99 |
| 2026Q1 | $0.92 | -$3.76 | -$3.43 | -$3.43 |
| 2025Q4 | $0.32 | $9.38 | -$4.53 | -$4.53 |
| 2025Q3 | $0.27 | $36.71 | -$0.46 | -$0.46 |
| 2025Q2 | $0.33 | -$1.88 | $3.14 | $3.13 |
KYNB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.64 |
| 2026Q1 | 0% | -0.45 |
| 2025Q4 | 0% | 0.23 |
| 2025Q3 | 0% | 0.06 |
| 2025Q2 | 0% | -0.70 |
KYNB
Price: $7.97
52 week price:
Earnings Per Share: -12.85 USD
P/E Ratio: -0.54
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 34.4 million